Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Valganciclovir MeSH Descriptor Data 2026


MeSH Heading
Valganciclovir
Tree Number(s)
D03.633.100.759.758.399.454.250.300.500
Unique ID
D000077562
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077562
Scope Note
A ganciclovir prodrug and antiviral agent that is used to treat CYTOMEGALOVIRUS RETINITIS in patients with AIDS, and for the prevention of CYTOMEGALOVIRUS INFECTIONS in organ transplant recipients who have received an organ from a CMV-positive donor.
Entry Term(s)
Ganciclovir L-valyl Ester
Valcyt
Valcyte
Valganciclovir Hydrochloride
Pharm Action
Antiviral Agents
Registry Numbers
GCU97FKN3R
0
4P3T9QF9NZ
Related Numbers
4P3T9QF9NZ
CAS Type 1 Name
L-Valine, 2-((2-amino-3,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester
Public MeSH Note
2019; VALGANCICLOVIR was indexed under GANCICLOVIR/analogs & derivatives 1999-2018
History Note
2019 (1999)
Date Introduced
2019/01/01
Last Updated
2019/01/01
Valganciclovir Preferred
Valcyte Narrower
Valganciclovir Hydrochloride Narrower
Valcyt Narrower
page delivered in 0.123s